Whole-genome sequencing (WGS) is a fundamental technology for research to advance precision medicine, but the limited availability of portable and user-friendly workflows for WGS analyses poses a major challenge for many research groups and hampers scientific progress. Here we present Sarek, an open-source workflow to detect germline variants and somatic mutations based on sequencing data from WGS, whole-exome sequencing (WES), or gene panels. Sarek features (i) easy installation, (ii) robust portability across different computer environments, (iii) comprehensive documentation, (iv) transparent and easy-to-read code, and (v) extensive quality metrics reporting. Sarek is implemented in the Nextflow workflow language and supports both Docker and Singularity containers as well as Conda environments, making it ideal for easy deployment on any POSIX-compatible computers and cloud compute
Introduction
Whole-genome sequencing (WGS) and whole-exome sequencing (WES) technologies opens up new avenues for research and for clinical applications, with many large initiatives launched worldwide. While much effort has been invested in novel sequencing analysis software, the importance of providing and maintaining workflows to combine software in an efficient and reproducible manner has been underestimated and too few resources are typically dedicated to address this issue. This is of particular importance for somatic variant analysis and especially for analysis of complex cancer genomes, where a combination of tools is still required for optimal sensitivity and specificity and to detect various types of gene mutations and other abnormalities (Alioto et al., 2015) . Some encouraging solutions have been presented in recent years, including SeqMule (Guo et al., 2015) , SpeedSeq (Chiang et al., 2015) , Bcbio-nextgen, and DNAp (Causey et al., 2018) . While all of the above represent commendable and important efforts, we have not found any workflow solution that in our opinion fulfils all of the following important user aspects: (i) easy installation, (ii) robust portability across different compute environments, (iii) comprehensive documentation, (iv) transparent and easy-to-read code, and (v) extensive quality metrics reporting. Here we present Sarek, an easy-to-install community-maintained workflow, offering a complete and scalable solution for germline and somatic variant detection, annotation and quality control.
Sarek supports several reference genomes and can handle data from WGS, WES and gene panels, and is intended to be used both as a production workflow at core facilities and as a standalone tool for individual research groups. By using Docker or Singularity containers, Sarek installs easily on all POSIX compatible systems such as Linux and Mac OS X and is designed to work on compute environments dedicated to handle sensitive personal data without direct internet access-a situation expected to become increasingly common with growing data security awareness.
Methods

Operation: Workflow overview and software
Sarek offers a portable workflow for germline and somatic variant detection, annotation and quality control based on WGS, WES or gene panel data, using a range of state-of-the-art software and data resources in the field (Table 1, Figure 1 ). In the pre-processing step, sequence reads are aligned to the reference Table 1 . Software required and implemented in Sarek. A list of all the software required and currently implemented in Sarek. All analysis and quality metrics software are installed automatically when Sarek is launched.
Figure 1. Schematic overview of the Sarek workflow for analysis of germline and somatic variants.
A schematic overview including some of the main analysis software implemented in the Sarek workflow. A more comprehensive list of the currently implemented software is given in Table 1 .
genome with BWA-MEM (Li, 2013), followed by deduplication and recalibration with GATK (McKenna et al., 2010) . For germline samples, single-nucleotide variants and small insertion/deletions are detected with HaplotypeCaller (McKenna et al., 2010) and Strelka2 (Kim et al., 2018) , and structural variations are detected with Manta (Chen et al., 2016) and TIDDIT (Eisfeldt et al., 2017) . For somatic samples, somatic single-base mutations (SSM) and small somatic insertion/deletion mutations (SIM) are detected by GATK4 Mutect2 (Cibulskis et al., 2013) and Strelka2 (Kim et al., 2018) . Somatic structural variants (including copy-number variation), as well as ploidy and sample purity are detected by Manta (Chen et al., 2016) , ASCAT (Van Loo et al., 2010), and Control-FREEC (Boeva et al., 2012) . All variants are annotated for potential functional effects with snpEff (Cingolani et al., 2012) and VEP (McLaren et al., 2016) . Importantly, Sarek also generates a wide range of quality control metrics using FastQC, QualiMap (Okonechnikov et al., 2016 ), BCFtools (Li, 2011 ), Samtools (Li et al., 2009 ), and VCFtools (Danecek et al., 2011 , visualized as an aggregated quality control review across samples with MultiQC (Ewels et al., 2016) .
Portability and reproducibility
Sarek is implemented in Nextflow (Di Tommaso et al. 2017 ), a workflow language designed specifically for bioinformatics applications. Nextflow has a transparent design, making the Sarek code easy to read, adjust and extend. Compared to the Bpipe workflow language (used in for example DNAp), Nextflow offers superior support for different execution environments, like Slurm, Sun Grid Engine, LSF and Kubernetes, and includes native support for cloud compute environments including Google Cloud and AWS. Support for AWS batch gives the possibility to easily distribute thousands of batch jobs on Amazon Web Services. Sarek is part of a rapidly growing community effort of well documented and community-tested Nextflow pipelines, and adheres to the nf-core portability and documentation guidelines (Ewels et al., 2019) . To facilitate easy installation and to ensure reproducibility, all Sarek required tools are managed in Docker or Singularity (Kurtzer et al., 2017) containers, or a Conda environment. While Docker is a widely appreciated container solution, it is not always allowed at high-performance computing centers because of the involved security risks, making Singularity the preferred choice at these sites (Kurtzer et al., 2017) . This is of particular importance for computer environments designed for handling sensitive personal data, where a high level of data security has to be maintained across multiple projects and users.
Implementation: Equipment and resource usage
Sarek can be installed and executed on any POSIX-compatible computer system. To run a full WGS analysis, including both germline and somatic variants from a tumour/normal dataset with 90x/90x read coverage, we recommend a minimum of 16 cores on a node with 128 GB RAM, and at least 4 TB available free storage (in addition to the initial FASTQ files) in the input/ output working directory. Of this, about 1.4 TB will be allocated for BAM files, annotated VCF files and CNV files, but excluding GVCF files (Table 2) . At the end of the run, 2.3 TB temporary data can be removed, unless the user plans to perform re-runs from intermediate processing states. Many processes are distributed across cores by dividing the genome into smaller chunks, each being handled as a separate core job, with all the results being merged and sorted in a final step. Some of the used software are parallelized by design, while for others Sarek uses a scatter-gather approach to efficiently distribute the processing load across CPU cores and reduce the wall clock runtime.
Installation and testing
Sarek is run from a computer system with a local installation of Nextflow and support for either Conda environments, Docker or Singularity containers. Nextflow can automatically fetch the Sarek source code from GitHub. All software dependencies are encapsulated in Docker or Singularity containers which are downloaded from Docker Hub, or built in a new Conda environment using Bioconda (Grüning et al., 2018) . As such, cumbersome software installations by the user are completely avoided. Configuration files allow tailoring to specific user needs and incomplete runs are easily restarted from any stage in the workflow process. Sarek comes with a small test dataset and a suite of tests to verify the installation. This is also used for Continuous Integration testing with GitHub Actions.
Results
To test performance in terms of resource usage and biological results, Sarek was run on a medulloblastoma WGS tumour/ normal dataset from a sample with high tumour cell content (∼98%), and with a curated "Gold Set" of verified somatic mutations from a previous benchmark study (Alioto et al., 2015) . In line with the above benchmark study, Sarek (version 2.5.2) was executed with WGS germline and somatic variant calling using a 90X/90X tumour/normal dataset (accession number EGAD00001001859, read sets EGAR00001387019-24 and EGAR00001387025-32). Runs were performed on a single 48-thread node with a local direct attached storage (DAS): A Dell PowerEdge R740 server, with two Intel Xeon Gold 6126 with a total of 24 cores (48 threads) CPUs, 756 GB memory, and 100 TB SCv3020 Compellent Storage. The complete Sarek run including preprocessing followed by both germline and somatic variant calling and annotation took 48 hours and 21 minutes, and required about three times more storage than the original input data (Table 2) . Notably, the complete Sarek run was executed by a single command, with fully automated installation, execution, and efficient job distributions of the more than 15 different software tools to complete the analysis and provide quality control metrics, without any manual intervention needed during the two-day run. To ensure that the Sarek output was biologically sound, we calculated precision, recall and F1 statistics for the Sarek output based on the "Gold Set" of somatic single-base mutations (SSM) and somatic insertion/deletion mutations (SIM) as previously defined (Alioto et al., 2015) . Using the intersection of the output from the two somatic variant callers (GATK4 Mutect2 and Strelka2), Sarek provided accuracy measures for SSMs (F1 score = 0.80) and SIMs (F1 score = 0.58) in the top range of the 18 somatic variant calling procedures included in the original benchmarking study on this data set (Table 3) , indicating that the workflow operates as intended. The sample purity was estimated to be 100%, as compared to 98% previously reported for this sample. For somatic structural variants and ploidy, no relevant benchmark data was available, and therefore no quantitative assessment beyond previously published results for the implemented software could be performed, but the integrity of the runs were checked by comparing the results of Manta, ASCAT, and Control-FREEC run within Sarek and as stand-alone.
Use case
Sarek has been extensively tested and applied on various WGS datasets, including thousands of samples for germline variant analyses, and hundreds of paired tumour/normal samples for somatic mutation analyses. In addition, Sarek has also been successfully tested on WES data and gene panels. Below we present a standard use case with a tumour/normal WGS dataset as input, running both germline and somatic variant analyses.
Input data
For a somatic variant analysis, the user should provide the sequencing FASTQ files from both tumour and normal control tissue from the same individual, described in a tab-delimited TSV file (here: samples.tsv). Each line of the TSV file contains information about a sequence data file, including: The identifier of the individual, the gender (XX or XY), the status of the sample (0 for Normal or 1 for Tumour), the identifier of the sample, the sequencing lane (if samples are multiplexed across multiple lanes), and the paths to the FASTQ file of the first and second read in the read-pair. Relapse samples from the same individual are also supported.
Running Sarek on WGS data with Singularity containers
Running Sarek with Singularity container on a computer system supporting Java 8 requires only installation of Nextflow and Singularity. A full analysis run starting from FASTQ files including mapping, recalibration, variant calling and annotation, Nextflow will recognize the workflow name and will download the specified version (2.5.2) of the pipeline from GitHub, including the corresponding container, as well as fetching the required reference files from AWS-iGenomes. The default reference genome is human GRCh38, but Sarek also supports GRCh37 and nearly 30 other genomes directly accessible from iGenomes. Alternatively, users can manually supply Sarek with other reference genomes. Non-default parameters and links to local reference files are handled in accordance with nf-core guidelines. User configuration profiles can be stored locally or centrally at https://github.com/nf-core/configs.
Output
A full Sarek run will produce a large number of output files, but the main results consist of (i) a set of annotated variants in VCF files from the various included tools for both germline and somatic variants, (ii) tumour sample purity and ploidy results for somatic samples, and (iii) a broad set of QC metrics. A detailed description of all output files is given at the Sarek documentation pages.
Discussion
Human WGS is transforming medical research, and provides a foundation to develop novel clinical applications and improve health care. An important aspect to harvesting the potential of WGS is however to empower the research community with adequate bioinformatics tools, and reproducible bioinformatics workflows are important drivers of scientific progress by making complex processing of large datasets feasible for a wide range of researchers. While we are highly appreciative of existing workflows for cancer and non-cancer variant detection, we argue that there is no one-size-fits-all solution and more initiatives are needed to serve the large and diverse research user community, especially for WGS data. Sarek builds on a philosophy of reasonably narrow, independent workflows, written in the domain-specific language Nextflow. In our experience, this is an effective strategy to simplify workflow maintenance at sequencing core facilities, and to allow easy deployment and modifications by individual research groups.
Sarek efficiently utilizes cloud and high-performance compute clusters and installs easily across compute environments.
Sarek provides annotated VCF files, CNV reports and quality metrics for germline and cancer samples from raw FASTQ sequencing data in about 48 hours for 90X/90X WGS data (as demonstrated here), in a few hours for WES data, and within minutes for gene panels (in-house data, not presented here). Ongoing efforts aim to develop add-on ranking and visualization modules and to efficiently extract clinically and biologically relevant findings, to help advance basic and translational research.
Conclusion
Sarek is a portable and reproducible workflow to detect germline and somatic variants from WGS, WES and gene panel data. It includes extensive analysis and quality control metrics, while still being limited to a relatively narrow scope to (Alioto et al., 2015) achieve optimal usability, functionality and transparency.
Sarek is flexible with a low threshold for user modifications, and is thus well adapted to the current requirements in the research community. Thanks to its design, it installs easily and reproducibly on all POSIX compatible computer systems, including secure compute environments for sensitive personal data with indirect Internet access.
Data availability
Source data European Genome-phenome Archive: A comprehensive assessment of somatic mutation detection in cancer using whole genome sequencing. https://www.ebi.ac.uk/ega/datasets/ EGAD00001001859. Read sets EGAR00001387019-24 and EGAR00001387025-32 were analysed.
These data are held under restricted access. Readers wishing to apply for access to the data must first apply through the ICGC Data Access Compliance Office (https://icgc.org/daco) and complete the data access form. Access will be granted to those whose projects conform to the goals and policies of ICGC. Help with completing the data access form is available at https:// icgc.org/daco/help-guide-section.
The workflow itself comes with a prebuilt profile with a complete configuration for automated testing, including links to a small test dataset.
Software availability
Sarek is available at: https://nf-co.re/sarek. Source code available at: https://github.com/nf-core/sarek.
Archived source code at time of publication: https://doi. org/10. 5281/zenodo.3579102 (Garcia et al., 2019) . 1.
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3. Sarek is based on Nextflow, a popular tool for defining computational workflows. In order to process NGS data, i.e., generating annotated variant calls ready for downstream analyses, multiple complex software tools need to be executed. This is not only computationally demanding, but also labor-intensive due to operators having to install and maintain a complicated collection of software as well as diagnose failed analysis runs, often resulting in high management overhead compared to the total computation time (Yakneen and Waszak, 2020 ) . Sarek aims to minimize the installation and management time overhead by building a NGS workflow on top of Nextflow, automatically installing the required software components. These software consist of some of the state-of-the-art tools in read mapping, variant calling and annotation and quality control. Sarek is a welcome addition to the toolkit of bioinformaticians looking for an NGS analysis workflow, which can be easily installed on a HPC cluster or cloud environment. The article is well-written and clear to understand. While I'm happy to recommend indexing of the manuscript also in the present form, I have a few suggestions how to improve it:
4.
Open Peer Review
Major comments:
While some of the existing NGS workflows are mentioned, I would appreciate it if Sarek was compared to these approaches in more detail. Is there functionality that is currently missing from Sarek that is present in one of the other workflows?
Typically in NGS data analysis, a lot of time can be spent on debugging failed runs to find out whether one of the tools failed, if the data is corrupted/missing or if there was a hardware error. How does Sarek support run diagnostics and relaunching failed jobs?
How does Sarek combine variant calls when multiple callers are used for a variant type?
Somatic single nucleotide and indel variant calls from Sarek were shown to match well with a 1 2 1 4.
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Somatic single nucleotide and indel variant calls from Sarek were shown to match well with a previously defined gold standard callset. No benchmark data was available for more complex somatic variants and variant calling accuracy for germline variants was not evaluated. I am interested in seeing more comprehensive tests to cover all germline and somatic variant types.
I would appreciate it if a minimal test dataset together with instructions and a suite of automated tests was provided with Sarek. This would make it easier for the user to test out an installation as well as raising issues in GitHub.
Minor comments:
How easy it is for users to modify or extend Sarek by for example adding a new variant caller to the workflow? This could be explored in more detail in text.
It would be good to easily see which tools are used to call and analyze each variant type. This information could be added either to Fig 1, Table 1 or both.
FreeBayes is included in Figure 1 but missing from Table 1 .
The wording in "To facilitate easy installation and to ensure reproducibility, all Sarek required tools are managed in Docker or Singularity (Kurtzer et al., 2017) containers, or a Conda environment." should be clarified --are all tools being maintained in all the three systems?
When running Sarek with default options, it crashes in the tool version check. It took me a while to figure out this was due to the default "-profile" argument of "standard" which seems to assume Singularity is available. It would be good to improve error messages so that it is easier to understand the underlying cause. A minimal installation and testing procedure mentioned above would help in this regard.
Typo: "Whole-genome sequencing (WGS) and whole-exome sequencing (WES) technologies opens…" -> "...open".
